Suppr超能文献

正常及肿瘤性淋巴细胞中二肽基氨基肽酶IV和II的细胞化学

Cytochemistry of dipeptidylaminopeptidase IV and II in normal and neoplastic lymphoid cells.

作者信息

Invernizzi R, Bertolino G, Girino M, Perseghin P, Michienzi M, Nano R

出版信息

Blut. 1985 May;50(5):277-85. doi: 10.1007/BF00319753.

Abstract

Cytochemical methods were used to determine the distribution of dipeptidylaminopeptidase IV (DAP IV) and II (DAP II) in lymphoid cell populations from patients with lymphoproliferative diseases. Special attention was paid to unusual intracellular distribution patterns which might correlate with the presence of various membrane markers. In healthy patients, about 50% of the circulating lymphocytes were found to be positive to both reactions, the intracellular distribution patterns being variable. The DAP IV reaction was negative in all B-CLL cases. In 2 cases of T-CLL with phenotype E+ OKT3+T4-T8+ one was negative and one was weakly positive, while two cases of T-CLL with phenotype E+ OKT3+T4+T8- were both strongly positive. The other non-T lymphoproliferative diseases studied were negative for DAP IV, while one T-ALL and three T-lymphoma cases showed a strong granular or diffuse distribution. The DAP II reaction was strongly positive in all the T lymphoproliferative diseases studied, irrespective of their immunological phenotype. This reaction was also weakly positive in some cases of plasmocytoma and lymphoplasmacytoid lymphoma.

摘要

采用细胞化学方法测定淋巴增生性疾病患者淋巴样细胞群体中二肽基氨基肽酶IV(DAP IV)和二肽基氨基肽酶II(DAP II)的分布。特别关注了可能与各种膜标志物存在相关的异常细胞内分布模式。在健康患者中,约50%的循环淋巴细胞对两种反应均呈阳性,细胞内分布模式各不相同。在所有B细胞慢性淋巴细胞白血病(B-CLL)病例中,DAP IV反应均为阴性。在2例表型为E+OKT3+T4-T8+的T细胞慢性淋巴细胞白血病(T-CLL)病例中,1例为阴性,1例为弱阳性,而2例表型为E+OKT3+T4+T8-的T-CLL病例均为强阳性。所研究的其他非T细胞淋巴增生性疾病的DAP IV均为阴性,而1例T细胞急性淋巴细胞白血病(T-ALL)和3例T细胞淋巴瘤病例表现为强颗粒状或弥漫性分布。在所研究的所有T细胞淋巴增生性疾病中,无论其免疫表型如何,DAP II反应均为强阳性。在一些浆细胞瘤和淋巴浆细胞样淋巴瘤病例中,该反应也呈弱阳性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验